James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 8,035 shares at $13.42 ($108K) on 2016-06-01, disclosed to the SEC on 2016-06-03.
Open-market purchase of $108k RETA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |